Alopecia Areata Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update

Synopsis

• In 2022, there will be more than 36 million prevalent cases of lopecia areata across 16 pharmaceutical markets
• No FDA-approved marketed drugs are available for Alopecia areata; however, there are several treatments used off-label to manage Alopecia Areata
• Drugs currently in Phase III stage of clinical development are inhibitors targeting the tyrosine kinase, JAK1
• Commercial sponsors dominate clinical trial development in Alopecia areata, with the US emerging as the key country for conducting trials in Alopecia areata
• Deals involving licensing of Alopecia areata assets are the most common type of deals globally
• There are three upcoming future market catalysts in the Alopecia areata space

Scope

• Disease Landscape
• Disease Overview
• Epidemiology Overview
• Treatment Overview
• Marketed Products Assessment
• Pipeline Assessment
• Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
• Late-to-mid-stage Pipeline Drugs
• Phase Transition Success Rate and Likelihood of Approval
• Clinical Trials Assessment
• Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
• Enrolment Analytics, Site Analytics, Feasibility Analysis
• Deals Landscape
• Mergers, Acquisitions, and Strategic Alliances by Region
• Overview of Recent Deals
• Commercial Assessment
• Key Market Players
• Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline
• Develop business strategies by understanding the trends shaping and driving the Alopecia areata market
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Alopecia areata market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships